Drug companies plan to raise prices on vital medicines to fund R&D, but they already spend more on shareholder returns MarketWatch Nawigacja wpisu Tesla price cuts are the 'right medicine at the right time,’ analyst says – Yahoo Finance Making family medicine a more attractive specialty: strategies to … – PLOS
